Sanofi is a global biopharmaceutical company committed to improving lives through innovative healthcare solutions. With a strong presence in over 100 countries, Sanofi focuses on vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes, and cardiovascular conditions.
At Sanofi, we believe in progress through collaboration, diversity, and inclusion. Our mission is to empower our teams to make a difference in patients’ lives.
Job Description
Key Responsibilities:
As an Associate Scientific Writer, you will:
✔ Develop specialized medical/scientific content (manuscripts, abstracts, posters, slide decks) under supervision.
✔ Support end-to-end publication and medical education content development.
✔ Ensure compliance with documentation and approval processes (PromoMats/iEnvision).
✔ Build expertise in assigned therapeutic areas and collaborate with stakeholders.
✔ Work with healthcare professionals to refine publication content.
✔ Assist in publication-need analysis and execute publication plans.
✔ Coordinate with vendors and internal teams for timely, high-quality deliverables.
People & Stakeholder Management:
- Engage with medical professionals to align content with scientific needs.
- Collaborate with Scientific Communication teams, Product Managers, and Medical Science Liaisons (MSLs).
Performance & Process:
- Deliver high-quality medical writing within deadlines.
- Support field medical communication and publication planning.
- Optimize content based on end-user feedback.
Eligibility Criteria
Experience:
- 1-3 years in medical/scientific writing (pharma/healthcare/academia).
Soft Skills:
- Strong stakeholder management & communication.
- Ability to work independently and in a team.
Technical Skills:
- Therapeutic area knowledge.
- Publication submission experience (optional).
- Project management skills (a plus).
Education:
- Advanced degree (Life Sciences/Pharmacy/Medicine or related field).
Language:
- Fluent English (written & spoken).
How to Apply?
📌 Last Date: May 10, 2025
